Predicting the response to a triptan in migraine using deep attack phenotyping: A feasibility study

BACKGROUND: Triptans, specific symptomatic medications for migraine, are not effective in a proportion of patients, or in all attacks, hence the importance of identifying predictors of response. Our aim was to investigate the association between the efficacy of oral frovatriptan 2.5 mg and clinical...

Descripción completa

Detalles Bibliográficos
Autores principales: Viana, Michele, Sances, Grazia, Terrazzino, Salvatore, Zecca, Chiara, Goadsby, Peter J, Tassorelli, Cristina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7859670/
https://www.ncbi.nlm.nih.gov/pubmed/32955929
http://dx.doi.org/10.1177/0333102420959786

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7859670/
https://www.ncbi.nlm.nih.gov/pubmed/32955929
http://dx.doi.org/10.1177/0333102420959786

Ejemplares similares